Metis Global Partners LLC Acquires 8,961 Shares of Ventas, Inc. $VTR

Metis Global Partners LLC lifted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 7.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 125,935 shares of the real estate investment trust’s stock after acquiring an additional 8,961 shares during the quarter. Metis Global Partners LLC’s holdings in Ventas were worth $9,745,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Deutsche Bank AG boosted its stake in shares of Ventas by 0.7% during the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after acquiring an additional 27,688 shares during the period. Capital Analysts LLC lifted its holdings in Ventas by 2.0% during the 4th quarter. Capital Analysts LLC now owns 18,644 shares of the real estate investment trust’s stock worth $1,443,000 after purchasing an additional 366 shares during the last quarter. Portfolio Design Labs LLC acquired a new stake in Ventas during the 4th quarter worth approximately $215,000. Fox Run Management L.L.C. acquired a new stake in Ventas during the 4th quarter worth approximately $429,000. Finally, Waddell & Associates LLC lifted its holdings in Ventas by 57.8% during the 4th quarter. Waddell & Associates LLC now owns 13,346 shares of the real estate investment trust’s stock worth $1,033,000 after purchasing an additional 4,891 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

Ventas Price Performance

Shares of NYSE VTR opened at $84.65 on Thursday. The stock has a market capitalization of $41.15 billion, a PE ratio of 153.91, a P/E/G ratio of 1.77 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The business has a fifty day moving average price of $85.06 and a two-hundred day moving average price of $82.44. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas’s revenue was up 22.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.5%. Ventas’s payout ratio is currently 378.18%.

Insider Buying and Selling at Ventas

In related news, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently weighed in on VTR. JPMorgan Chase & Co. lifted their price target on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Evercore reissued an “outperform” rating and set a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. UBS Group lifted their price target on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a report on Monday, May 4th. Finally, Wells Fargo & Company lifted their price target on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $95.19.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.